Martin S W, Stevens A J, Brennan B S, Reis M L, Gifford L A, Rowland M, Houston J B
Department of Pharmacy, University of Manchester, United Kingdom.
Pharm Res. 1995 Dec;12(12):1980-6. doi: 10.1023/a:1016260426830.
To determine the permeability characteristics of the rat air pouch model of inflammation using permeability extremes within which the NSAIDs S[+] ibuprofen, piroxicam and diclofenac could be evaluated.
Permeability was calculated using concentration data obtained following intrapouch and intravenous administration of [3H]-water, [14C]-urea, [14C]-inulin and [125I]-albumin and compared to similar data obtained for the three NSAIDs.
Similar permeability values (5-6.5 ml hr-1) were obtained for the three NSAIDS which fell between the permeability extremes of the molecular weight markers [3H]-water (9.7 ml hr-1), [14C]-urea (6.8 ml hr-1), [14C]-inulin (1.0 ml hr-1) and [125I]-albumin (0.6 ml hr-1). Coadministration of equipotent anti-inflammatory doses of the NSAIDs did not affect local blood flow to the air pouch (as assessed by urea kinetics) but did reduced vascular permeability (as assessed by albumin flux into the pouch).
Comparison of the NSAIDs with the permeabilities of the molecular weight markers indicates that a perfusion rate limitation probably exists. Systemic absorption is complete over the first two hours following intrapouch administration of the NSAIDs, therefore albumin flux into the pouch is insufficient to materially affect the permeability of the NSAIDs. However, subsequently (post 5hr) albumin concentration in the pouch rises sufficiently to lower the effective flux of the NSAIDs.
利用通透性极限来确定大鼠气囊炎症模型的通透性特征,在该极限范围内可对非甾体抗炎药S[+]布洛芬、吡罗昔康和双氯芬酸进行评估。
通过囊内和静脉注射[3H] - 水、[14C] - 尿素、[14C] - 菊粉和[125I] - 白蛋白后获得的浓度数据计算通透性,并与三种非甾体抗炎药的类似数据进行比较。
三种非甾体抗炎药获得了相似的通透性值(5 - 6.5毫升/小时),其介于分子量标记物[3H] - 水(9.7毫升/小时)、[14C] - 尿素(6.8毫升/小时)、[14C] - 菊粉(1.0毫升/小时)和[125I] - 白蛋白(0.6毫升/小时)的通透性极限之间。联合给予等效抗炎剂量的非甾体抗炎药不影响气囊局部血流(通过尿素动力学评估),但确实降低了血管通透性(通过白蛋白流入气囊评估)。
将非甾体抗炎药与分子量标记物的通透性进行比较表明可能存在灌注率限制。非甾体抗炎药囊内给药后的前两小时全身吸收完成,因此白蛋白流入气囊不足以实质性影响非甾体抗炎药的通透性。然而,随后(5小时后)气囊中白蛋白浓度充分升高以降低非甾体抗炎药的有效通量。